Boston Scientific Corp
A maker of medical devices for less-invasive procedures, Boston Scientific builds tools like the WATCHMAN heart implant, the FARAPULSE system for treating irregular heartbeats, and devices for endoscopy, urology, and pain management, sold in more than a hundred countries. Founded in 1979 by John Abele and Pete Nicholas, the company began as a holding company for a steerable-catheter maker and took its name from its Massachusetts roots plus the founders' commitment to scientific rigor. The two founders reportedly met while watching their children play soccer.
Granted 2.1K
Granted 3.8K
Granted 3.8K
Granted 3.8K · Bought 3.6K
Granted 3.8K · Bought 4.5K
Granted 5.1K · Bought 2.0K
Granted 3.8K
Granted 1.8K
Granted 838
Granted 3.8K
Bought 1.8K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Mahoney Michael FChairman, President & CEO, Director · 1 transaction | -21.6% | 1.40M | — | — | — |
| Butcher Arthur CEVP& Grp Pres, MedSurg & APAC · 2 transactions | +2.8% | 78.1K | 2.1K | — | — |
| Wichmann David SDirector · 1 transaction | +9.1% | 45.4K | 3.8K | — | — |
| Zane Ellen MDirector · 1 transaction | +15.7% | 27.9K | 3.8K | — | — |
| Ludwig Edward JDirector · 2 transactions | +41% | 25.4K | 3.8K | 3.6K | — |
| Habiger David CDirector · 3 transactions | +146.6% | 13.9K | 3.8K | 4.5K | — |
| Morano Susan EDirector · 4 transactions | +128.4% | 13.8K | 5.1K | 2.0K | — |
| Mega Jessica LDirector · 1 transaction | +46.1% | 12.0K | 3.8K | — | — |
| O'Connor Padraig AndrewEVP, Global Operations · 2 transactions | +22.7% | 7.9K | 1.8K | — | — |
| Woodworth EmilySVP, Global Controller and CAO · 2 transactions | +19.5% | 2.9K | 838 | — | — |
| Weber Christophe PierreDirector · 4 transactions | — | 2.6K | 3.8K | — | — |
| Pegus CherylDirector · 1 transaction | — | 1.8K | — | 1.8K | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: +11.8K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.